A study was conducted in northern Iran in areas of very high, high and moderately low incidence of oesophageal cancer. Morphine metabolites in urine as an indicator of opium use, and a variety of nutritional and biochemical measures, including salivary antipyrine half-life, were determined in households with a case of oesophageal cancer and in control households. Results on 1,590 individuals showed that the prevalence of appreciable levels (greater than or equal to 1 microgram/ml) of urinary morphine metabolites was much higher in areas of high and very high incidence of oesophageal cancer than in low-incidence areas, particularly for those under age 50 years in both sexes, where a 6-fold difference was seen. Members of households with a case of oesophageal cancer had a higher prevalence of positive urinary morphine metabolite findings than members of control households from the same village. Salivary anti-pyrine half-life (AP-T1/2), as a measure of hepatic drug metabolizing capacity, was estimated in 120 subjects. No relationship was seen with use of opium, region of residence, case-control status of household, age or sex. Experimental studies have meanwhile identified mutagenic substances with carcinogenic potential in opium pipe scrapings, used widely in the study region, opium pyrolysates and morphine pyrolysates. Our data give additional support to the hypothesis that opium use, in the form of its pyrolysates, is one of the factors involved in the aetiology of oesophageal cancer in the region.
and , The GLIM System, Release 3. Numerical Algorithms Group, Oxford (1978).
Castonguay, Proc. nat. Acad. Sci. (Wash.), 80, 6694 (1983)
, and , Antipyrine halflife of the population in the high esophageal cancer incidence area in northern China. In: Proceedings of the 13th International Cancer Congress, Seattle, Washington USA, Sept. 8–15, 1982, Excerpta Medica, Amsterdam (1983).
Chang, Life Sci., 22, 855 (1978)
, , , and , Use of drugs in the evaluation of carcinogen metabolism in man. In: and (eds.), Screening tests in chemical carcinogenesis, IARC Scientific Publications No. 12, IARC, Lyon (1976).
Conney, Fed. Proc., 36, 1647 (1977)
Cook-Mozaffari P J, Azordegan F, Day N E, Ressicaud A, Sabai C, Aramesh B, Oesophageal cancer studies in the Caspian Littoral of Iran: Results of a case-control study, 10.1038/bjc.1979.54
Crespi, Lancet, 11, 217 (1979)
Antipyrine metabolite profile as a tool in the assessment of the activity of different drug oxidizing enzymes in man. Docioral thesis, State University of Leiden, Leiden (1980).
, , and , The possible role of opium and tobacco pyrolysates in oesophageal cancer. In: (ed.), Carcinogens and mutagens in the environment, Vol. III: Naturally occurring compounds, pp. 59–71, CRC Press, Boca Raton (1983).
, , , , , , , , , , , , and , Characterization and identification of six mutagens in opium pyrolysates implicated in oesophageal cancer in Iran. Mutation Res. in press (1985).
Hewer, Lancet, 11, 494 (1978)
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER. Annual Report 1983, pp. 41–43, IARC, Lyon (1983).
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER. Annual Report 1984, pp. 41–42, IARC, Lyon (1984).
IRAN/IARC STUDY GROUP, J. nat. Cancer Inst., 59, 1127 (1977)
Kalamegham R., Krishnaswamy K., Krishnamurthy S., Bhargava R. N. K., Metabolism of drugs and carcinogens in man: Antipyrine elimination as an indicator, 10.1002/cpt197925167
, and , Epidemiology of oesophageal cancer with special reference to nutritional studies among the Turkoman of Iran. In: Advances in modern human nutrition, Pathotox, New York (1980).
, , and , The negligible role of alcohol and tobacco in the aetiology of oesophageal cancer in Iran-A case-Control study. In: (ed.), Prevention and detection of cancer, Part II: Detection, pp. 1149–1159, Marcel Dekker, New York (1978).
Mahboubi E, Kmet J, Cook P J, Day N E, Ghadirian P, Salmasizadeh S, Oesophageal Cancer Studies in the Caspian Littoral of Iran: The Caspian Cancer Registry, 10.1038/bjc.1973.138
Malaveille, Carcinogenesis., 3, 557 (1982)
O'neill, Int. J. Cancer, 26, 617 (1980)
Perry, Carcinogenesis, 4, 227 (1983)
Roberfroid, Chem. biol. Interact., 47, 175 (1983)
Sotaniemi, Europ. J. Drug Metab. Phamcokinet., 1, 39 (1973)
Tschanz, Cancer Res., 37, 3881 (1977)
Vessel, Environ. Hlth. Perspect., 20, 161 (1977)
Bibliographic reference
Ghadirian, P ; Stein, G F ; Gorodetzky, C ; Roberfroid, Marcel ; Mahon, G A ; et. al. Oesophageal cancer studies in the Caspian littoral of Iran: some residual results, including opium use as a risk factor.. In: International journal of cancer. Journal international du cancer, Vol. 35, no. 5, p. 593-7 (1985)